皮肤纤维瘤突起体的非侵入性成像技术的进步:一篇综述
Yanci A Algarin1, Anika Pulumati2, Jiali Tan3
1Eastern Virginia Medical School, Norfolk, Virginia, USA.
The Australasian journal of dermatology
|October 3, 2024
概括
超声波 (US) 和磁共振成像 (MRI) 是评估皮质纤维瘤突起体 (DFSP) 和计划手术的关键. 像PET-CT这样的先进成像显示了管理复发性DFSP和治疗反应的前景.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 手术病理学手术病理学
背景情况:
- 皮质纤维瘤突起 (DFSP) 是一种罕见的,局部具有攻击性的软组织肉瘤.
- 外交部外务政策表现出潜入式增长和高复发率,需要精确的管理.
- 准确评估DFSP程度对于有效的外科规划和治疗至关重要.
研究的目的:
- 为了评估9种成像模式的疗效,对皮质纤维素瘤突起体 (DFSP) 进行评估.
- 在DFSP中比较各种成像技术的诊断能力.
- 为DFSP手术前规划和复发监测提供最佳成像策略的信息.
主要方法:
- 对九种成像方式的系统审查:超声波 (美国),高频多普勒超声波 (HFUS),计算机断层扫描 (CT),正子发射断层扫描-计算机断层扫描 (PET-CT),磁共振成像 (MRI),高分辨率MRI (HR-MRI),磁共振光谱 (MRS),光学连贯性断层扫描 (OCT) 和皮肤镜.
- 对检测瘤边界,肌肉入侵,深度和转移的成像性能进行分析.
- 对US和MRI等关键模式的灵敏度和特异性的比较.
主要成果:
- 超声波 (美国) 在初始评估,检测肌肉侵袭 (81.8%的灵敏度) 和定义瘤边界 (100%的特异性) 中表现出色.
- 磁共振成像 (MRI) 对于术前评估和复发监测有价值,可以准确评估瘤深度 (67%的灵敏度,100%的特异性).
- 计算机断层扫描 (CT) 用于怀疑骨参与或转移;PET-CT有助于监测先进/复发的DFSP和治疗反应.
结论:
- 超声波 (US),MRI和CT是皮肤纤维瘤突起体 (DFSP) 管理的主要成像方式.
- 新兴技术 (HR-MRI,PET-CT,MRS,OCT) 显示出改进诊断和手术规划的潜力.
- 多模式成像集成可以增强DFSP管理,特别是复杂的病例,需要进一步研究.
更多相关视频
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
2.8K
07:16Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
Published on: April 25, 2025
902
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
